Zinc inhibition of caspase-3 activation does not protect HeLa cells from apoptotic cell death
Zinc inhibition of caspase-3 activation does not protect HeLa cells from apoptotic cell death
复制标题
DOI:
10.1006/taap.2001.9239
复制
发表时间:
2001-08-15
影响因子:
3.8
通讯作者:
Kang, YJ
中科院分区:
文献类型:
--
作者:
Lambert, JC;Wang, GW;Kang, YJ
Zinc is proposed to be antiapoptotic for it has been shown to inhibit late events of apoptotic pathways such as Ca2+/Mg-2+-dependent endonuclease cleavage of chromatin DNA, poly-ADP ribose polymerase cleavage, and caspase-3 activity. Because caspase-3 is a critical executioner caspase in apoptosis, this study was undertaken to examine specifically a correlation between zinc inhibition of caspase-3 activation and apoptosis in HeLa cells. Cultured HeLa cells were exposed to 100 rhoM ZnCl2 for 1 h prior to 12 h treatment with 1.0 muM doxorubicin (DOX), an important anticancer agent that causes apoptosis in a wide variety of tumor cells. Western blot analysis of HeLa cells treated with DOX for 12 h revealed that DOX caused proteolytic activation of caspase-3 and zinc inhibited this activation. Interestingly, zinc did not inhibit DOX-induced apoptosis as measured by a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay. Furthermore, a microculture tetrazolium assay confirmed that cell death occurred in the presence of zinc. These results demonstrate that zinc specifically inhibits DOX-induced activation of caspase-3 in HeLa cells, but does not suppress DOX-induced apoptosis or otherwise cell death, thus suggesting DOX-induced caspase-3 activation may not play a major role in overall cell death and/or non-caspase-3 pathways are involved in DOX-induced apoptosis in HeLa cells. (C) 2001 Academic Press.